Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3

Experimental Eye Research

Volumn 83, Issue 4, 2006, Pages 858-864

  Nareyeck, Gordon ^a   Zeschnigk, Michael ^b   Prescher, Gabriele ^c   Lohmann, Dietmar R ^b   Anastassiou, Gerasimos ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Dr Eberhard and Partner   (Germany)

Author keywords

cell line; karyotype; microsatellite analysis; monosomy 3; uveal melanoma

Indexed keywords

ARTICLE; CHROMOSOME 3; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; KARYOTYPE; MELANOMA CELL; MONOSOMY; PRIORITY JOURNAL; UNIPARENTAL DISOMY; UVEA MELANOMA;

CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; KARYOTYPING; MELANOMA; MICROSATELLITE REPEATS; MONOSOMY; UVEAL NEOPLASMS;

EID: 33748208280     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.04.004     Document Type: Article

References (21)

1. Albert D.M., Ruzzo M.A., McLaughlin M.A., Robinson N.L., Craft J.L., and Epstein J. Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest. Ophthalmol. Vis. Sci. 25 11 (1984) 1284-1299
2. Bittner K., Liszio C., Blumberg P., Schonherr E., and Kresse H. Modulation of collagen gel contraction by decorin. Biochem. J. 314 Pt 1 (1996) 159-166
3. Bonicel P., Michelot J., Bacin F., Papon J., Kemeny J.L., Moins N., Morvan D., and Madelmont J.C. Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma. Melanoma Res. 10 5 (2000) 445-450
4. Bornstein M.B. Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. Lab. Invest. 7 2 (1958) 134-137
5. De Waard-Siebinga I., Blom D.J., Griffioen M., Schrier P.I., Hoogendoorn E., Beverstock G., Danen E.H., and Jager M.J. Establishment and characterization of an uveal-melanoma cell line. Int. J. Cancer 62 2 (1995) 155-161
6. Hurks H.M., Valter M.M., Wilson L., Hilgert I., van den Elsen P.J., and Jager M.J. Uveal melanoma: no expression of HLA-G. Invest. Ophthalmol. Vis. Sci. 42 13 (2001) 3081-3084
7. Kan-Mitchell J., Mitchell M.S., Rao N., and Liggett P.E. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 30 5 (1989) 829-834
8. Kujala E., Makitie T., and Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44 11 (2003) 4651-4659
9. Luyten G.P., Naus N.C., Mooy C.M., Hagemeijer A., Kan-Mitchell J., Van Drunen E., Vuzevski V., De Jong P.T., and Luider T.M. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int. J. Cancer 66 3 (1996) 380-387
10. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M., Pe'er J., Trent J.M., Meltzer P.S., and Hendrix M.J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155 3 (1999) 739-752
11. Maniotis A.J., Chen X., Garcia C., DeChristopher P.J., Wu D., Pe'er J., and Folberg R. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab. Invest. 82 8 (2002) 1031-1043
12. Mitelman F. An International System for Human Cytogenetic Nomenclature (1995), S. Karger, Basel
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 1-2 (1983) 55-63
14. Nareyeck G., Seidler D.G., Troyer D., Rauterberg J., Kresse H., and Schonherr E. Differential interactions of decorin and decorin mutants with type I and type VI collagens. Eur. J. Biochem. 271 16 (2004) 3389-3398
15. Prescher G., Bornfeld N., and Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J. Natl. Cancer Inst. 82 22 (1990) 1765-1769
16. Prescher G., Bornfeld N., Hirche H., Horsthemke B., Jockel K.H., and Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 9010 (1996) 1222-1225
17. Scholes A.G., Damato B.E., Nunn J., Hiscott P., Grierson I., and Field J.K. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest. Ophthalmol. Vis. Sci. 44 3 (2003) 1008-1011
18. Tschentscher F., Prescher G., Zeschnigk M., Horsthemke B., and Lohmann D.R. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet. Cytogenet. 122 1 (2000) 13-17
19. Tschentscher F., Hüsing J., Hölter T., Kruse E., Dresen I.G., Jöckel K.H., Anastassiou G., Schilling H., Bornfeld N., Horsthemke B., Lohmann D.R., and Zeschnigk M. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res. 63 10 (2003) 2578-2584
20. Walker T.M., Van Ginkel P.R., Gee R.L., Ahmadi H., Subramanian L., Ksander B.R., Meisner L.F., Albert D.M., and Polans A.S. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch. Ophthalmol. 120 12 (2002) 1719-1725
21. White V.A., Chambers J.D., Courtright P.D., Chang W.Y., and Horsman D.E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83 2 (1998) 354-359